Everolimus-eluting bioresorbable scaffold
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Everolimus-eluting bioresorbable scaffold, covering 2017-12-15 to 2017-12-15. Get the full timeline:
Most recent: Clinical Trial Update: Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease [Phase 4]